GitLab (GTLB) 10-Q 6 Sep 22 2023 Q2 Quarterly report Financial data

Cover

Cover - shares shares in Millions	6 Months Ended
	Jul. 31, 2022	Aug. 30, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2022
Document Transition Report	false
Entity File Number	001-40895
Entity Registrant Name	GITLAB INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-1861035
Title of 12(b) Security	Class A common stock, par value $0.0000025per share
Trading Symbol	GTLB
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Address, Address Line One	251 Little Falls Drive
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19808
Entity Central Index Key	0001653482
Current Fiscal Year End Date	--01-31
Current Fiscal Year Focus	2023
Current Fiscal Period Focus	Q2
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		87
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		61.8

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2022	[1]	Jan. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 410,757		$ 884,672
Short-term investments	519,433		50,031
Accounts receivable, net of allowance for doubtful accounts of $1,340 and $1,098 as of July 31, 2022 and January 31, 2022, respectively	89,344		77,233
Deferred contract acquisition costs, current	23,648		24,363
Prepaid expenses and other current assets	20,807		15,544
Total current assets	1,063,989		1,051,843
Property and equipment, net	5,459		3,271
Equity method investment	14,581		0
Goodwill	8,145		8,145
Intangible assets, net	5,081		6,285
Deferred contract acquisition costs, non-current	13,945		14,743
Other long-term assets	4,219		7,151
TOTAL ASSETS	1,115,419		1,091,438
CURRENT LIABILITIES:
Accounts payable	5,379		4,984
Accrued expenses and other current liabilities	24,474		24,571
Accrued compensation and benefits	15,503		32,820
Deferred revenue, current	201,348		179,224
Total current liabilities	246,704		241,599
Deferred revenue, non-current	24,401		32,568
Other non-current liabilities	13,994		18,002
TOTAL LIABILITIES	285,099		292,169
Commitments and contingencies (Note 14)
STOCKHOLDERS’ EQUITY:
Preferred stock, $0.0000025 par value; 50,000 shares authorized as of July 31, 2022 and January 31, 2022; no shares issued and outstanding as of July 31, 2022 and January 31, 2022	0		0
Additional paid-in capital	1,413,491		1,320,479
Accumulated deficit	(638,460)		(553,337)
Accumulated other comprehensive income	3,456		7,724
Total GitLab stockholders’ equity	778,487		774,866
Noncontrolling interests	51,833		24,403
TOTAL STOCKHOLDERS’ EQUITY	830,320		799,269
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	1,115,419		1,091,438
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	0		0
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	$ 0		$ 0
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2022		Jan. 31, 2022
Allowance for doubtful accounts	$ 1,340		$ 1,098
STOCKHOLDERS’ EQUITY:
Preferred stock, par value (in USD per share)	$ 0.0000025		$ 0.0000025
Preferred stock, shares authorized (in shares)	50,000,000		50,000,000
Preferred stock, shares issued (in shares)	0		0
Preferred stock, shares outstanding (in shares)	0		0
Assets of consolidated variable interest entity	$ 1,115,419	[1]	$ 1,091,438
Liabilities	285,099	[1]	292,169
Variable Interest Entity, Primary Beneficiary
STOCKHOLDERS’ EQUITY:
Assets of consolidated variable interest entity	60,945		17,732
Liabilities	$ 3,589		$ 3,663
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)	$ 0.0000025		$ 0.0000025
Common stock, shares authorized (in shares)	1,500,000,000		1,500,000,000
Common stock, shares issued (in shares)	83,025,000		27,141,000
Common stock, shares outstanding (in shares)	83,025,000		27,141,000
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)	$ 0.0000025		$ 0.0000025
Common stock, shares authorized (in shares)	250,000,000		250,000,000
Common stock, shares issued (in shares)	65,746,000		119,747,000
Common stock, shares outstanding (in shares)	65,746,000		119,747,000
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Revenue	$ 101,041	$ 58,127	$ 188,448	$ 108,057
Cost of revenue	13,030	7,192	22,878	13,617
Gross profit	88,011	50,935	165,570	94,440
Operating expenses:
Sales and marketing	80,689	44,165	147,399	83,019
Research and development	39,520	22,603	71,350	43,943
General and administrative	33,104	13,998	54,996	23,337
Total operating expenses	153,313	80,766	273,745	150,299
Loss from operations	(65,302)	(29,831)	(108,175)	(55,859)
Interest income	3,064	45	3,590	99
Other income (expense), net	1,500	(9,991)	19,948	(11,043)
Loss before income taxes and loss from equity method investment	(60,738)	(39,777)	(84,637)	(66,803)
Loss from equity method investment, net of tax	(816)	0	(1,019)	0
Provision for (benefit from) income taxes	(57)	989	2,454	2,245
Net loss	(61,497)	(40,766)	(88,110)	(69,048)
Net loss attributable to noncontrolling interest	(2,473)	(577)	(2,987)	(922)
Net loss attributable to GitLab	$ (59,024)	$ (40,189)	$ (85,123)	$ (68,126)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted
Basic (in USD per share)	$ (0.40)	$ (0.75)	$ (0.58)	$ (1.29)
Diluted (in USD per share)	$ (0.40)	$ (0.75)	$ (0.58)	$ (1.29)
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted
Basic (in shares)	147,797,000	53,424,000	147,248,000	52,941,000
Diluted (in shares)	147,797,000	53,424,000	147,248,000	52,941,000
Subscription—self-managed and SaaS
Revenue	$ 88,936	$ 51,860	$ 165,859	$ 96,768
Cost of revenue	10,671	5,809	18,604	10,758
License—self-managed and other
Revenue	12,105	6,267	22,589	11,289
Cost of revenue	$ 2,359	$ 1,383	$ 4,274	$ 2,859

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (61,497)	$ (40,766)	$ (88,110)	$ (69,048)
Foreign currency translation adjustments	(1,128)	8,487	(3,792)	9,389
Net change in unrealized gains or losses on available-for-sale securities	(2,454)	0	(2,523)	0
Comprehensive loss including noncontrolling interest	(65,079)	(32,279)	(94,425)	(59,659)
Net loss attributable to noncontrolling interest	(2,473)	(577)	(2,987)	(922)
Foreign currency translation adjustments attributable to noncontrolling interest	(732)	0	(2,047)	0
Comprehensive loss attributable to noncontrolling interest	(3,205)	(577)	(5,034)	(922)
Comprehensive loss attributable to GitLab	$ (61,874)	$ (31,702)	$ (89,391)	$ (58,737)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total		Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ (231,222)		$ 0	$ 0	$ 186,892	$ (398,199)	$ (19,915)	$ 0
Convertible Preferred Stock, beginning balance (in shares) at Jan. 31, 2021	79,551,000
Convertible Preferred Stock, beginning balance at Jan. 31, 2021	$ 424,904
Convertible Preferred Stock, ending balance (in shares) at Jul. 31, 2021	79,551,000
Convertible Preferred Stock, ending balance at Jul. 31, 2021	$ 424,904
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2021			1,151,000	52,468,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)				(13,000)
Repurchase of common stock	(590)				(590)
Issuance of common stock related to vested exercised stock options (in shares)				1,025,000
Issuance of common stock related to vested exercised stock options	4,420				4,420
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				413,000
Vesting of early exercised stock options	1,453				1,453
Stock-based compensation expense	8,663				8,663
Other comprehensive (loss) income	9,389						9,389
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	26,450							26,450
Net loss	(69,048)					(68,126)		(922)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2021			1,151,000	53,893,000
Stockholders' Equity, ending balance at Jul. 31, 2021	(250,485)		$ 0	$ 0	200,838	(466,325)	(10,526)	25,528
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ (245,469)		$ 0	$ 0	192,534	(426,136)	(19,013)	7,146
Convertible Preferred Stock, beginning balance (in shares) at Apr. 30, 2021	79,551,000
Convertible Preferred Stock, beginning balance at Apr. 30, 2021	$ 424,904
Convertible Preferred Stock, ending balance (in shares) at Jul. 31, 2021	79,551,000
Convertible Preferred Stock, ending balance at Jul. 31, 2021	$ 424,904
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2021			1,151,000	53,223,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				571,000
Issuance of common stock related to vested exercised stock options	2,319				2,319
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				99,000
Vesting of early exercised stock options	753				753
Stock-based compensation expense	5,232				5,232
Other comprehensive (loss) income	8,487						8,487
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	18,959							18,959
Net loss	(40,766)					(40,189)		(577)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2021			1,151,000	53,893,000
Stockholders' Equity, ending balance at Jul. 31, 2021	(250,485)		$ 0	$ 0	200,838	(466,325)	(10,526)	25,528
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	(250,485)		0	0	200,838	(466,325)	(10,526)	25,528
Stockholders' Equity, beginning balance	$ 799,269		$ 0	$ 0	1,320,479	(553,337)	7,724	24,403
Convertible Preferred Stock, beginning balance (in shares) at Jan. 31, 2022	0
Convertible Preferred Stock, beginning balance at Jan. 31, 2022	$ 0
Convertible Preferred Stock, ending balance (in shares) at Jul. 31, 2022	0
Convertible Preferred Stock, ending balance at Jul. 31, 2022	$ 0
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2022			27,141,000	119,747,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)			55,368,000	(55,368,000)
Issuance of common stock related to vested exercised stock options (in shares)	1,409,000			1,386,000
Issuance of common stock related to vested exercised stock options	$ 11,413				11,413
Issuance of common stock under employee stock purchase plan (in shares)			289,000
Issuance of common stock under employee stock purchase plan	9,554				9,554
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				(19,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)			227,000
Vesting of early exercised stock options	2,960				2,960
Stock-based compensation expense	55,218				52,246			2,972
Other comprehensive (loss) income	(6,315)						(4,268)	(2,047)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	57,673				16,839			40,834
Deconsolidation of Meltano Inc.	(11,342)							(11,342)
Net loss	(88,110)					(85,123)		(2,987)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2022			83,025,000	65,746,000
Stockholders' Equity, ending balance at Jul. 31, 2022	830,320	[1]	$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 818,202		$ 0	$ 0	1,355,224	(579,436)	6,306	36,108
Convertible Preferred Stock, beginning balance (in shares) at Apr. 30, 2022	0
Convertible Preferred Stock, beginning balance at Apr. 30, 2022	$ 0
Convertible Preferred Stock, ending balance (in shares) at Jul. 31, 2022	0
Convertible Preferred Stock, ending balance at Jul. 31, 2022	$ 0
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2022			74,049,000	73,583,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)			8,461,000	(8,461,000)
Issuance of common stock related to vested exercised stock options (in shares)				652,000
Issuance of common stock related to vested exercised stock options	6,193				6,193
Issuance of common stock under employee stock purchase plan (in shares)			289,000
Issuance of common stock under employee stock purchase plan	9,554				9,554
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				(28,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)			226,000
Vesting of early exercised stock options	814				814
Stock-based compensation expense	37,747				34,992			2,755
Other comprehensive (loss) income	(3,582)						(2,850)	(732)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	22,889				6,714			16,175
Net loss	(61,497)					(59,024)		(2,473)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2022			83,025,000	65,746,000
Stockholders' Equity, ending balance at Jul. 31, 2022	830,320	[1]	$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 830,320	[1]	$ 0	$ 0	$ 1,413,491	$ (638,460)	$ 3,456	$ 51,833
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022		Jul. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (88,110)		$ (69,048)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	55,218		8,663
Amortization of intangible assets	1,176		169
Depreciation expense	1,286		0
Amortization of deferred contract acquisition costs	21,618		15,099
Gain from deconsolidation of Meltano Inc.	(17,798)		0
Loss from equity method investment	1,290		0
Net amortization of premiums or discounts on short-term investments	(1,293)		0
Unrealized foreign exchange (gain) loss	(1,572)		9,839
Other non-cash (income) expense	469		(143)
Changes in assets and liabilities:
Accounts receivable	(13,568)		(7,059)
Prepaid expenses and other current assets	(5,488)		(215)
Deferred contract acquisition costs	(21,210)		(15,112)
Other long-term assets	2,700		(1,918)
Accounts payable	528		(1,189)
Accrued expenses and other current liabilities	90		4,910
Accrued compensation and benefits	(16,680)		(2,385)
Deferred revenue	17,549		19,613
Other long-term liabilities	(696)		135
Net cash used in operating activities	(64,491)		(38,641)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(520,664)		(50,000)
Proceeds from maturities of short-term investments	50,031		0
Purchases of property and equipment	(3,234)		0
Deconsolidation of Meltano Inc.	(9,620)		0
Net cash used in investing activities	(483,487)		(50,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	11,311		7,652
Issuance of common stock under employee stock purchase plan	9,554		0
Repurchase of common stock in a tender offer	0		(590)
Contributions received from noncontrolling interests, net of issuance costs	57,673		26,450
Payments of deferred offering costs	0		(825)
Net cash provided by financing activities	78,538		32,687
Impact of foreign exchange on cash and cash equivalents	(4,475)		(642)
Net decrease in cash and cash equivalents	(473,915)		(56,596)
Cash, cash equivalents, and restricted cash at beginning of period	887,172		282,850
Cash, cash equivalents, and restricted cash at end of period	413,257		226,254
Supplemental disclosure of cash flow information:
Cash paid for income taxes	309		631
Cash donations	0		1,000
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	2,960		1,453
Unpaid deferred offering costs	0		473
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents	410,757	[1]	226,254
Restricted cash, current included in prepaid expenses and other current assets	2,500		0
Total cash, cash equivalents and restricted cash	$ 413,257		$ 226,254
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. While the Company is headquartered in San Francisco, California, it operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Correction of an Immaterial Error in Prior Period During the quarter ended October 31, 2021, the Company identified an immaterial error in which $50.0 million of short-term investments were incorrectly reflected within cash and cash equivalents as previously reported for the six months ended July 31, 2021. In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 250, Accounting Changes and Error Corrections , we evaluated the materiality of the error from quantitative and qualitative perspectives, and concluded that the error was immaterial to the Company's prior period interim financial statements. Since this error was not material to any prior period interim or annual financial statements, no amendments to previously filed interim or annual periodic reports are required. Consequently, the Company has adjusted for this error by revising its historical condensed consolidated statements of cash flows for the six months ended July 31, 2021, reclassing $50.0 million from the cash and cash equivalents balance at the end of period to purchases of short-term investments. Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal 2023 and 2022 refer to the fiscal year ending January 31, 2023 and the fiscal year ended January 31, 2022, respectively. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes and valuation of intangibles assets . The Company bases these estimates on historical and anticipated results, tre nds, and various other assumptions, including the impact of the COVID-19 pandemic, that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. The novel coronavirus, or COVID-19, pandemic has created, and may continue to create, significant uncertainty in macroeconomic conditions. The global impact of COVID-19 continues to rapidly evolve, and the Company will continue to monitor the situation and the effects on its business and operations closely. The Company does not yet know the full extent of potential impacts on its business or operations or on the global economy as a whole, particularly if the COVID-19 pandemic continues and persists for an extended period of time. Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned subsidiaries and a variable interest entity for which our Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation. Summary of Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2” of the Company’s Annual Report on Form 10-K f or the fiscal year ended January 31, 2022, except for the addition of policies in respect of short-term investments - marketable securities, equity method investment in Meltano Inc., the Company’s former wholly-owned subsidiary, and an update to the stock-based compensation policy to cover the Company’s recently granted performance stock units (“PSUs”). Short-Term Investments - Marketable Securities The Company classifies its marketable securities with stated maturities of three months and greater as short-term investments due to its ability to use these securities to support the Company’s current operations. As of July 31, 2022, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. Unrealized gains and losses are recorded as a separate component of other comprehensive loss, net of tax. Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the condensed consolidated statements of operations. The Company periodically reviews its available-for-sale securities to determine if there has been an other-than-temporary decline in fair value. Factors considered in determining whether a loss is other-than-temporary include, but are not limited to: the length of time and extent a security’s fair value has been below its cost, the financial condition and near-term prospects of the investee, the credit quality of the security’s issuer, likelihood of recovery and the Company’s intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. No changes in fair value due to impairment have been recorded in earnings for available-for-sale securities during the periods presented. Equity Method Investment The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in an erstwhile subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in our condensed consolidated statements of operations. The carrying value of the Company’s equity method investments is reported in equity method investment in the condensed consolidated balance sheets. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Stock-Based Compensation Our PSUs issued to the senior members of its management team are subject to a revenue performance condition and service conditions. The number of PSUs that will ultimately vest will depend on the revenue achieved by the Company in fiscal 2025 relative to the defined target. The fair value of PSUs is measured at the market price of the Company’s Class A common stock on the date of grant and compensation costs related to these awards are recognized on a graded-vesting method over the requisite service period. Recently Adopted Accounting Standards In December 2019, the FASB issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC 740, Income Taxes in order to reduce cost and complexity of its application. The Company adopted ASU 2019-12 as of February 1, 2022 with no material impact. Recently Issued Accounting Standards Not Yet Adopted In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820) (“Topic 820”): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (“ASU 2022-03”). ASU 2022-03 clarifies the guidance in Topic 820 that a contractual restriction on the sale of an equity security should not be considered in measuring fair value, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. For public companies, the amendments to ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. The adoption of ASU 2022-03 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“Topic 842”). Topic 842 supersedes the lease requirements in ASC Topic 840, Leases . Under Topic 842, lessees are required to recognize assets and liabilities on the condensed consolidated balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. For public companies, Topic 842 is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company has elected to use the extended transition period that allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies under the JOBS Act. For as long as the Company remains an “emerging growth company,” the new guidance is effective for annual reporting periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The adoption of ASU 2016-02 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. Since the Company follows private company’s adoption timelines, this new guidance is effective for the Company for its fiscal year beginning February 1, 2023. The Company is currently evaluating the effect of the adoption of ASU 2016-13 on its condensed consolidated financial statements. The effect will largely depend on the composition and credit quality of the Company's portfolio of financial assets and the economic conditions at the time of adoption.

Revenues

Revenues	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenues	3. Revenues Disaggregation of Revenue The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Subscription—self-managed and SaaS $ 88,936 88 % $ 51,860 89 % $ 165,859 88 % $ 96,768 90 % Subscription—self-managed 66,896 66 41,412 71 126,615 67 77,527 72 SaaS 22,040 22 10,448 18 39,244 21 19,241 18 License—self-managed and other $ 12,105 12 % $ 6,267 11 % $ 22,589 12 % $ 11,289 10 % License—self-managed 10,009 10 4,776 8 18,786 10 8,443 8 Professional services and other 2,096 2 1,491 3 3,803 2 2,846 2 Total revenue $ 101,041 100 % $ 58,127 100 % $ 188,448 100 % $ 108,057 100 % Total Revenue by Geographic Location The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 United States $ 84,123 $ 48,833 $ 156,397 $ 90,520 Europe 14,750 8,353 27,738 15,466 Asia Pacific 2,168 941 4,313 2,071 Total revenue $ 101,041 $ 58,127 $ 188,448 $ 108,057 During each of the three and six months ended July 31, 2022, the United States accounted for 83% of total revenue for each period presented. During each of the three and six months ended July 31, 2021, the United States accounted for 84% of total revenue for each period presented. No other individual country exceeded 10% of total revenue for any of the periods presented. The Company operates its business as a single reportable segment. Deferred Revenue During the three and six months ended July 31, 2022, $67.0 million and $105.8 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the applicable reporting period presented. During the three and six months ended July 31, 2021, $39.8 million and $61.3 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the applicable reporting period presented. Remaining Performance Obligations As of July 31, 2022 and January 31, 2022, the aggregate amount of the transaction price allocated to billed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $361.9 million and $312.4 million, respectively. As of July 31, 2022, the Company expects to recognize approximately 69% of the transaction price as product or services revenue over the next 12 months and the remainder thereafter. Concentration of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions that hold its cash, cash equivalents, restricted cash, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances. To minimize credit losses on accounts receivable, the Company extends credit to customers based on an evaluation of their ability to pay amounts due under contractual arrangement. The Company uses various distribution channels. Th ere were two distribution channel entities whose balance in aggregate represented 35% of the accounts receivabl e balance as of July 31, 2022, and individually represented 19% and 16% of the accounts receivabl e balance, respectively, for the same period. There was one distribution channel entity whose balance represented 14% of the accounts receivable balance as of January 31, 2022.

Cash, Cash Equivalents and Shor

Cash, Cash Equivalents and Short-Term Investments	6 Months Ended
	Jul. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents and Short-Term Investments	4. Cash, Cash Equivalents and Short-Term Investments The following table summarizes the Company’s cash, cash equivalents and short-term investments by category (in thousands): As of July 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 281,339 $ — $ — $ 281,339 Money market funds 111,927 — — 111,927 U.S. Treasury securities 7,499 — — 7,499 U.S. Agency securities 9,996 — (4) 9,992 Total cash and cash equivalents $ 410,761 $ — $ (4) $ 410,757 Short-term investments: Commercial paper 46,197 — (190) 46,007 Corporate debt securities 48,251 17 (202) 48,066 Municipal bonds 1,974 — (11) 1,963 Foreign government bonds 2,185 — (7) 2,178 U.S. Agency securities 18,585 20 (35) 18,570 U.S. Treasury securities 404,760 10 (2,121) 402,649 Total short-term investments $ 521,952 $ 47 $ (2,566) $ 519,433 As of January 31, 2022, the Company had $884.7 million of cash and $50.0 million of short-term investments, comprised of certificates of deposit with a bank with an original maturity of greater than three months at the date of purchase. Such investments were carried at amortized cost, which approximated their fair value and matured during the six months ended July 31, 2022. The Company uses the specific-identification method to determine an y realized gains or losses from the sale of our short-term investments classified as available-for-sale. During the three and six months ended July 31, 2022, the Company did not have any material realized gains or losses as a result of maturities or sales of short-term investments. During the three and six months ended July 31, 2022, the Company recorded $3.1 million and $3.6 million of interest income on cash equivalents and short-term investments, respectively, which includes $1.3 million of net amortization of premiums or discounts on short-term investments reported on the condensed consolidated statements of cash flows for the six months ended July 31, 2022. As of July 31, 2022 , the Company does not have an y cash equivalents and short-term investments that have been in a continuous unrealized gain or loss position for more than 12 months as of the periods presented. The following table summarizes unrealized losses on our cash equivalents and sh ort-term investments by category that have been in a continuous unrealized loss position for less than 12 months as of the periods presented (in thousands): Carrying Value Gross Unrealized Losses July 31, 2022 U.S. Agency securities $ 21,107 $ (39) Commercial paper 46,007 (190) Corporate debt securities 38,112 (202) Municipal bonds 1,963 (11) Foreign government bonds 2,178 (7) U.S. Treasury securities 398,843 (2,121) Total cash equivalents and short-term investments $ 508,210 $ (2,570) The following table classifies the Company’s short-term investments by contractual maturities (in thousands): July 31, 2022 January 31, 2022 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 375,663 $ 373,816 $ 50,031 $ 50,031 Due between 1 year to 3 years 146,289 145,617 — — Total $ 521,952 $ 519,433 $ 50,031 $ 50,031 All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements The Company determines fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instrumen ts such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. Financial assets measured at fair value on a recurring basis are summarized below (in thousands): Level 1 Level 2 Level 3 Fair Value July 31, 2022 (1) Cash equivalents: Money market funds $ 111,927 $ — $ — $ 111,927 U.S. Agency securities — 7,499 — 7,499 U.S. Treasury securities — 9,992 — 9,992 Short-term investments: Commercial paper — 46,007 — 46,007 Corporate debt securities — 48,066 — 48,066 Municipal bonds — 1,963 — 1,963 Foreign government bonds — 2,178 — 2,178 U.S. Agency securities — 18,570 — 18,570 U.S. Treasury securities — 402,649 — 402,649 Total $ 111,927 $ 536,924 $ — $ 648,851 (1) Exclu des $281.3 million in cash held in the Company’s bank accounts as of July 31, 2022.

Supplemental Financial Statemen

Supplemental Financial Statement Information	6 Months Ended
	Jul. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Balance Sheet Components	6. Supplemental Financial Statement Information Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2022 January 31, 2022 Prepaid software subscriptions $ 5,084 $ 3,950 Prepaid advertising costs 1,624 722 Security and other deposits 1,620 981 Prepaid insurance 1,221 4,309 Prepaid income taxes 3,678 3,168 Restricted cash (1) 2,500 — Interest receivable 1,294 49 Prepaid expenses for the Company’s events 715 266 Other prepaid expenses 733 1,834 Other current assets 2,338 265 Total prepaid expense and other current assets $ 20,807 $ 15,544 (1) Refer to “Note 7. Business Combination”. Property and Equipment, Net Property and equipment, net of the following (in thousands): July 31, 2022 January 31, 2022 Computer and office equipment $ 6,480 $ 3,049 Leasehold improvements 768 765 Others 92 — 7,340 3,814 Less: Accumulated depreciation (1) (1,881) (543) Total property and equipment, net (1) $ 5,459 $ 3,271 (1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment. Depreciation expense of property and equipment was $0.7 million and $1.3 million for the three and six months ended July 31, 2022, respectively, and zero for the respective periods last year. Other Long-Term Assets Other assets consisted of the following (in thousands): July 31, 2022 January 31, 2022 Security and other deposits $ 2,298 $ 2,832 Restricted cash (1) — 2,500 Deferred software implementation costs 1,119 969 Other long-term assets 802 850 Total other long-term assets $ 4,219 $ 7,151 (1) Refer to “Note 7. Business Combination”. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2022 January 31, 2022 Accrued expenses $ 12,881 $ 8,605 Income taxes payable 1,127 319 ESPP employee contributions 2,130 6,557 Indirect taxes payable 1,169 4,044 Acquisition related contingent cash consideration (1) 3,101 3,029 Acquisition related consideration withheld in escrow (1) 2,500 — Other current liabilities 1,566 2,017 Total accrued expenses and other current liabilities $ 24,474 $ 24,571 (1) Refer to “Note 7. Business Combination”. Accrued Compensation and Benefits Accrued compensation and benefits consisted of the following (in thousands): July 31, 2022 January 31, 2022 Accrued commissions $ 6,745 $ 8,417 Payroll taxes payable 1,382 14,506 Other accrued team member related payables 7,376 9,897 Total accrued compensation and benefits $ 15,503 $ 32,820 Other Long-Term Liabilities Other long-term liabilities consisted of the following (in thousands): July 31, 2022 January 31, 2022 Early exercised options liability $ 3,775 $ 6,837 Acquisition related contingent cash consideration (1) 5,046 4,929 Acquisition related consideration withheld in escrow (1) — 2,500 Deferred tax liabilities 1,725 379 Contingent liability for labor matters 2,510 2,573 Other long-term liabilities 938 784 Total other long-term liabilities $ 13,994 $ 18,002 (1) Refer to “Note 7. Business Combination”. Other Income (Expense), Ne t Other income (expense), net consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Gain from deconsolidation of Meltano Inc. (1) $ — $ — $ 17,798 $ — Foreign exchange gains (losses), net 1,646 (8,821) 2,506 (9,872) Other expense, net (146) (1,170) (356) (1,171) Total other income (expense), net $ 1,500 $ (9,991) $ 19,948 $ (11,043) (1) Refer to “Note 11. Joint Venture and Equity Method Investment”.

Business Combination

Business Combination	6 Months Ended
	Jul. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combination	7. Business Combination On December 3, 2021, th e Company completed the acquisition of Opstrace, Inc., a technology company based in San Francisco, California. The transaction was accounted for as a business combination. The acquisition date fair value of the consideration transferred consisted of the following (in thousands): Cash consideration $ 2,970 Fair value of common stock issued on closing 959 Contingent common stock consideration (classified under additional paid-in capital) 1,754 Contingent cash consideration (classified under accrued expenses and other current liabilities as of July 31, 2022) 3,007 Contingent cash consideration (classified under other long-term liabilities as of July 31, 2022) 4,893 Total consideration $ 13,583 Cash consideration includes $2.5 million held back as partial security for post-closing indemnification claims made within 18 months of the closing da te recorded in a ccrued expenses and other current liabilities on the condensed consolidated balance sheet as of July 31, 2022 and in other long-term liabilities as of January 31, 2022. As a result of acquisition, the fair value of the consideration transferred included contingent cash considerations of $7.9 million in aggregate. These contingent cash considerations are determined based upon the satisfaction of certain defined operational milestones and are remeasured at fair value at each reporting period through earnings. As the fair value is based on unobservable inputs, the liabilities are included in Level 3 of the fair value measurement hierarchy. There were no changes in the fair value of contingent considerations, except for accretion expense of $0.1 million and $0.2 million for the three and six months ended July 31, 2022, respectively. During the three and six months ended July 31, 2022, there were no measurement period adjustments identified and recorded. Results of operations of the business acquired have been included in our condensed consolidated financial statements subsequent to the date of acquisition. The revenue and net income (loss) earned by the business acquired following the acquisition are not material to our condensed consolidated results of operations. Pro forma statements have not been presented because they are not material to our condensed consolidated results of operations.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	6 Months Ended
	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	8. Goodwill and Intangible Assets, Net Goodwill The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of July 31, 2022 and January 31, 2022 $ 8,145 There was no goodwill impairment for any periods presented. Intangible Assets Intangible assets, net consisted of the following (in thousands): July 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (1,359) $ 4,841 2.3 Developed technology from asset acquisitions (1) 1,284 (1,044) 240 0.7 Total $ 7,484 $ (2,403) $ 5,081 January 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (334) $ 5,866 2.8 Developed technology from asset acquisitions (1) 1,402 (983) 419 1.3 Total $ 7,602 $ (1,317) $ 6,285 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles. Amortization expense was $0.6 million and $1.2 million for the three and six months ended July 31, 2022, respectively, and $0.1 million and $0.2 million for three and six months ended July 31, 2021, respectively. As of July 31, 2022 , future amortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2023 $ 1,188 2024 2,166 2025 1,727 Total future amortization $ 5,081

Team Member Benefit Plans

Team Member Benefit Plans	6 Months Ended
	Jul. 31, 2022
Retirement Benefits [Abstract]
Team Member Benefit Plans	9. Team Member Benefit Plans The Company contributes to defined c ontribution plans in a number of countries including a 401(k) savings plan for U.S.-based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were $0.8 million and $2.0 million for the three and six months ended July 31, 2022, respectively, and $0.5 million and $1.5 million for the three and six months ended July 31, 2021, respectively.

Equity

Equity	6 Months Ended
	Jul. 31, 2022
Equity [Abstract]
Equity	10. Equity In connection with the IPO, on October 18, 2021, the Company filed a restated certificate of incorporation that authorized the issuance of 1,500,000,000 shares of Class A common stock, 250,000,000 shares of Class B common stock, and 50,000,000 shares of preferred stock at $0.0000025 par value for each class of shares. Common stockholders are entitled to dividends when and if declared by the board of directors. No dividends have been declared to date. The holder of each share of Class A common stock is entitled to one vote and the holder of each share of Class B common stock is entitled to ten votes. Common Stock The Company had shares of common stock reserved for future issuance as follows (in thousands): July 31, 2022 January 31, 2022 Class A and Class B common stock Options issued and outstanding 14,888 17,146 Shares available for issuance under Equity Incentive Plans 21,870 18,248 RSUs and PSUs issued and outstanding 7,972 3,280 Shares reserved for issuance to charitable organizations 1,636 1,636 2021 ESPP 4,451 3,271 Total 50,817 43,581 Early Exercised Options (subject to a repurchase right) Certain stock option holders have the right to exercise unvested options, subject to a repurchase right held by the Company at the original exercise price, in the event of voluntary or involuntary termination of employment of the holder. As of July 31, 2022 and January 31, 2022, there wer e 388,331 an d 713,967 shares, respectively, of unvested options that had been early exercised and were subject to repurchase for a total liability of $3.8 million and $6.8 million , respectively. The liability associated with early exercised options is included in other long-term liabilities in the condensed consolidated balance sheets. For accounting purposes, issuance of shares will be recognized only on vesting. However, shares issued for the early exercise of options are included in issued and outstanding shares as they are legally issued and outstanding. Equity Incentive Plans In 2015, the Company adopted the 2015 Equity Incentive Plan (the “2015 Plan”), in which shares of common stock of the Company are reserved for issuance of stock options to team members, directors, or consultants. The options generally vest 25% upon completion of one year and then ratably over 36 months. Options generally expire ten years from the date of grant. All these options qualify as equity settled awards and contain no performance conditions. In September 2021, in connection with the IPO, the board of directors and stockholders approved the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor to the Company’s 2015 Plan (together the “Plans”). The 2021 Plan authorizes the award of both stock options, which are intended to qualify for tax treatment under Section 422 of the Internal Revenue Code, and nonqualified stock options, as well for the award of restricted stock awards (“RSAs”), stock appreciation rights (“SARs”), restricted stock units (“RSUs”), PSUs and stock bonus awards. Pursuant to the 2021 Plan, incentive stock options may be granted only to the Company’s team members. The Company may grant all other types of awards to its team members, directors, and consultants. The Company initially reserved 13,032,289 shares of its Class A common stock, plus any reserved shares of Class B common stock not issued or subject to outstanding grants under the 2015 Plan on the effective date of the 2021 Plan, for issuance as Class A common stock pursuant to awards granted under the 2021 Plan. The number of shares reserved for issuance under the 2021 Plan increases automatically on February 1 of each of the years from 2022 through 2031. The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): July 31, 2022 January 31, 2022 Available at beginning of period 18,248 4,796 Awards authorized 7,673 22,532 Options granted — (7,936) RSUs and PSUs granted (5,103) (3,290) RSUs cancelled and forfeited 161 10 Options cancelled and forfeited 849 2,044 Options repurchased 42 92 Available at end of period 21,870 18,248 In the event that shares previously issued u nder the above Plans are reacquire d by the Company, such shares shall be added to the number of shares then available for issuance under the Plans. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of su ch stock option will be added to the number of shares then available for issuance under the Plans. Both Plans allow the grantees to early exercise stock options. Stock Options, RSUs and PSUs The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2022 17,146 $ 11.83 8.24 $ 894.8 Options granted — — Options exercised (1,409) 8.29 Options cancelled (14) 10.02 Options forfeited (835) 13.60 Balances at July 31, 2022 14,888 $ 12.06 7.73 $ 675.0 Options vested at July 31, 2022 6,663 $ 8.24 7.02 $ 327.6 Options vested and expected to vest at July 31, 2022 14,888 $ 12.06 7.73 $ 675.0 No options were granted during the three months ended July 31, 2022 and the weighted-average grant-date fair value per share of options granted was $8.35 for the three months ended July 31, 2021. The aggregate intrinsic value of options exercised during the three months ended July 31, 2022 and 2021 was $25.8 million and $8.5 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. No options were granted during the six months ended July 31, 2022 and the weighted-average grant-date fair value per share of options granted was $7.90 for the six months ended July 31, 2021. The aggregate intrinsic value of options exercised during the six months ended July 31, 2022 and 2021 was $59.8 million and $25.8 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. As of July 31, 2022 and January 31, 2022, approximately $62.4 million and $80.3 million, respectively, of total unrecognized compensation cost was related to stock options granted, that is expected to be recognized over a weighted-average period of 2.4 years and 2.7 years, respectively. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. The following table summarizes the Company’s restricted stock units activity (in thousands): Number of Shares (1) Weighted- Balances at January 31, 2022 272 $ 82.11 Granted 4,738 52.28 Vested (242) 59.45 Canceled/forfeited (161) 58.47 Balances at July 31, 2022 4,607 $ 53.38 (1) The table above does not include 3 million RSUs issued to the Company’s founder and the CEO described below. These RSUs are grants of shares of the Company’s common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two As of July 31, 2022 and January 31, 2022, approximately $235.7 million and $21.5 million, respectively, of total unrecognized compensation cost was related to restricted stock units granted to team members other than the CEO, that is expected to be recognized over a weighted-average period of 3.5 years and 3.9 years, respectively. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. In June 2022, the Company granted 0.4 million PSUs to senior members of its management team subject to revenue performance condition and service conditions. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance condition is set to be achieved in fiscal 2025 and the service condition in the calendar year 2025. The Company recorded $0.7 million of stock-based compensation expense related to PSUs during the six months ended July 31, 2022. As of July 31, 2022, unrecognized stock-based compensation expense related to these PSUs was $18.5 million to be recognized over a period of 3.4 years. CEO Performance Award In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Mr. Sijbrandij, the Company’s co-founder and CEO, with an estimated aggregate grant date fair value of $8.8 million. The Company recorded $0.4 million and $0.8 million of stock-based compensation expense related to the CEO RSUs during the three and six months ended July 31, 2022, respectively. As of July 31, 2022, unrecognized stock-based compensation expense related to these RSUs was $6.8 million which will be recognized over the remaining derived service period of the respective tranches which ranges from 2 to 7 years. 2021 Employee Stock Purchase Plan (“ESPP”) In September 2021, the Company’s board of directors and its stockholders approved the 2021 Employee Stock Purchase Plan (“ESPP”) to enable eligible team members to purchase shares of the Company’s Class A common stock with accumulated payroll deductions and provides a 15% purchase price discount of the fair market value of the Company’s Class A common stock on the IPO date or purchase date, whichever is lower. The 2021 ESPP also provides up to a 27-month look-back period with four purchase dates in May and November of each year, and the first purchase occurred in May 2022. If the closing price of the Company’s Class A common stock on the first day of the current offering period is higher than the price on the last day of any applicable purchase period, the ESPP requires the price to be reset based on the lower fair market value and the offering period to be rolled over for a new period of 24 months. This reset and rollover was triggered on the May 31, 2022 purchase date. The original offering period commencing on the IPO date through November 30, 2023 was modified to a new offering period commencing June 1, 2022 through May 31, 2024 and the ESPP price was reset based on the closing price of the Company’s Class A common stock on May 31, 2022. In accordance with ASC 718, Stock-Based Compensation , the modification in respect of the reset of the ESPP price and rollover resulted in an incremental charge of stock-based compensation expense of $0.7 million during the three and six months ended July 31, 2022, and the remaining modification charge of $9.2 million will be recognized over the new offering period. The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model: Six Months Ended July 31, 2022 Risk-free interest rate 1.62% - 2.63% Volatility 44.95% - 52.76% Expected term (in years) 0.5 - 2.0 Dividend yield —% The Company record ed $9.7 million and $14.1 million of stock-based compensation expense related to the ESPP during the three and six months ended July 31, 2022, respectively. As of July 31, 2022, approximately $31.7 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.8 years. In May 2022, the Company issued 0.3 million shares of Class A common stock to team members through the ESPP. Stock-Based Compensation Expense The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Cost of revenue $ 1,585 $ 239 $ 2,375 $ 391 Research and development 11,339 1,541 16,375 2,506 Sales and marketing 14,851 1,687 21,902 3,126 General and administrative 9,972 1,765 14,566 2,640 Total stock-based compensation expense $ 37,747 $ 5,232 $ 55,218 $ 8,663 The corporate income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation expense was $2.2 million and $3.1 million for the three and six months ended July 31, 2022, respectively, and not material for the three and six months ended July 31, 2021.

Joint Venture and Equity Method

Joint Venture and Equity Method Investment	6 Months Ended
	Jul. 31, 2022
Noncontrolling Interest [Abstract]
Joint Venture and Equity Method Investment	11. Joint Venture and Equity Method Investment Joint Venture In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation . On March 29, 2022, JiHu closed its Series A-1 round of common stock financing where investors contributed $27.7 million, net of issuance costs. On July 1, 2022, JiHu closed its Series A-2 round of common stock financing where investors contributed $22.8 million, net of issuance costs. The Company accounted for these funding events as equity transactions with the carrying amount of the non-controlling interest adjusted to reflect the change in the ownership interest in JiHu, and the difference was recognized in the Company’s additional paid-in capital. Subsequent to the closing of both rounds, the Company retains control over JiHu with equity stake reduced from 72% to 56%. In March 2022, one of the potential investors who could not participate in the Series A-1 financing round provided a $2.9 million loan to JiHu as an advance pending a capital contribution. The loan was repayable within ten business days of receipt of capital contribution from the investor. JiHu received an equity contribution from this investor during the Series A-2 round and repaid the loan in full in July 2022. During the six months ended July 31, 2022, the board of directors of JiHu approved an employee stock option plan (“JiHu ESOP”) for its employees. During the three and six months ended July 31, 2022, the Company recognized $2.8 million and $3.0 million stock-based compensation expense related to JiHu ESOP, respectively. As of July 31, 2022, approximately $20.6 million of total unrecognized compensation cost was related to the JiHu ESOP that is expected to be recognized over 3.7 years. The Company considers the RSUs and stock option awards granted pursuant to the JiHu ESOP as potentially dilutive equity instruments that will result in dilution of the Company’s stake in JiHu upon vesting of such award (or, in the case of option awards granted pursuant to the JiHu ESOP, upon vesting and subsequent exercise into shares of JiHu common stock). Any such dilution will be accounted for as an equity transaction. Until such awards granted pursuant to the JiHu ESOP are vested (or, in the case of option awards, vested and ultimately exercised into shares of JiHu common stock), the Company will continue to record the recognized stock-compensation expense of JiHu as part of the noncontrolling interest. Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Revenue $ 1,020 $ 32 $ 2,113 $ 32 Cost of revenue 413 274 712 361 Gross profit (loss) 607 (242) 1,401 (329) Operating expenses: Sales and marketing 1,865 705 3,252 850 Research and development 1,909 333 2,837 661 General and administrative 3,539 945 4,293 1,579 Total operating expenses 7,313 1,983 10,382 3,090 Loss from operations (6,706) (2,225) (8,981) (3,419) Interest income 142 — 210 — Other income, net 339 49 1,012 1 Net loss before income taxes (6,225) (2,176) (7,759) (3,418) Net loss $ (6,225) $ (2,176) $ (7,759) $ (3,418) Net loss attributable to noncontrolling interest $ (2,473) $ (577) $ (2,987) $ (922) July 31, 2022 January 31, 2022 Cash and cash equivalents $ 58,323 $ 14,198 Property and equipment, net 845 769 Other assets 1,777 2,765 Total assets $ 60,945 $ 17,732 Total liabilities $ 3,589 $ 3,663 Equity Method Investment In April 2021, the Company reorganized Meltano Inc. (“Meltano”), which started as an internal project within the Company in July 2018, into a separate legal entity. The entity was funded by the Company’s contribution of intellectual property with the fair value of approximately $0.4 million and a preferred stock financing from third parties of $4.2 million, representing 12% ownership on a fully diluted basis. On April 4, 2022, Meltano closed its Series Seed-2 round of preferred stock financing and raised $7.2 million. Pursuant to this transaction, the board composition of Meltano changed and the Company no longer has the power to appoint the majority of the board of directors of Meltano. Consequently, despite having majority voting rights at the stockholder level, the Company no longer has control over Meltano. The loss of control of a majority owned subsidiary resulted in the deconsolidation of net assets of $9.4 million and non-controlling interest of Meltano of $11.3 million, recognition of retained interest at fair value of $15.9 million, and a gain of $17.8 million recorded in other income (expense), net during the six months ended July 31, 2022 . The fair value of retained interest was determined using Option Pricing Model (“OPM”) Backsolve approach based on the most recent funding round of preferred stock. As of the date of the loss of control, the basis difference between the fair value of investment in Meltano and the Company’s share in the net assets of Meltano was attributed to equity method goodwill. Effective April 4, 2022, the Company accounts for this investment under the equity method and has recorded $14.6 million in “equity method investment” on its condensed consolidated balance sheet as of July 31, 2022 . During the three and six months ended July 31, 2022, the Company recognized a loss from equity method investment of $(0.8) million and $(1.0) million, net of tax on the condensed consolidated statements of operations, respectively. As of July 31, 2022, the Company owns 98% of the common stock in Meltano. As of July 31, 2022

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes For the three and six months ended July 31, 2022, the Company recorded income tax benefit of $(0.1) million and income tax expense of $2.5 million on pretax loss of $60.7 million and $84.6 million, respectively. The income tax benefit for the three months ended July 31, 2022 was primarily related to an increase in domestic losses from operations as compared to the same period last year. The income tax expense for the six months ended July 31, 2022 related primarily to the Company's foreign and domestic operations and the establishment of a deferred tax liability relating to the deconsolidation of a majority-owned entity, Meltano, and simultaneous establishment of the Company's equity method investment. For the three and six months ended July 31, 2021, the Company recorded income tax expense of $1.0 million and $2.2 million on pretax loss of $39.8 million and $66.8 million, respectively. The income tax expense was primarily related to tax liability from the Company's foreign and domestic opera tions. The Company's provision for income taxes is based on its worldwide estimated annualized effective tax rate, except for jurisdictions for which a loss is expected for the year and no benefit can be realized for those losses, jurisdictions for which forecasted pre-tax income or loss cannot be estimated, and the tax effect of discrete items occurring during the period. The tax expense for jurisdictions for which a forecast cannot be estimated is based on actual taxes and tax reserves for the quarter. Under the provisions of ASC 740, Income Taxes , the determination of the Company’s ability to recognize its deferred tax assets requires an assessment of both negative and positive evidence when determining the Company’s ability to recognize its deferred tax assets. The Company determined that it was not more likely than not that the Company could recognize certain deferred tax assets. Evidence evaluated by the Company included operating results during the most recent three-year period and future projections, with more weight given to historical results than expectations of future profitability, which are inherently uncertain. Certain entities’ net losses in recent periods represented sufficient negative evidence to require a valuation allowance against its net deferred tax assets. This valuation allowance will be evaluated periodically and could be reversed partially or totally if business results have sufficiently improved to support realization of deferred tax assets. As of July 31, 2022, unrecognized tax benefits approximated $5.5 million, of which $0.8 million would affect the effective tax rate if recognized. The Company is unable to reasonably estimate the timing of the long-term payments or the amount by which the liability will increase or decrease. It is the Company’s policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. For the three and six months ended July 31, 2022 and 2021, the Company recognized an insignificant amount of interest and penalties related to unrecognized tax benefits. Accrued interest and penalties were $0.1 million as of each of July 31, 2022 and January 31, 2022.

Net Loss per Share

Net Loss per Share	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Net Loss per Share	13. Net Loss per Share The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Numerator: Net loss attributable to GitLab $ (59,024) $ (40,189) $ (85,123) $ (68,126) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 147,797 53,424 147,248 52,941 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.40) $ (0.75) $ (0.58) $ (1.29) Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): July 31, 2022 January 31, 2022 Shares subject to outstanding common stock options 14,888 17,146 Unvested RSUs in connection with business combination 15 16 Unvested early exercised stock options 388 714 Unvested RSUs and PSUs 7,972 3,264 Shares subject to the 2021 ESPP 65 256 Total 23,328 21,396

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies Contractual Obligations and Commitments The Company’s contractual commitments relate mainly to third-party non-cancellable hosting infrastructure agreements and subscription arrangements used in the ordinary course of business. There have been no material changes to the contractual obligations with a term of 12 months or longer since the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2022, except for a non-cancelable 3-year hosting infrastructure arrangement for an aggregate consideration of $7.4 million and a non-cancelable 3-year software subscription arrangement for an aggregate consideration of $2.3 million. See “Note 14. Commitments and Contingencies” in the Company’s Annual Report on Form 10-K filed with the SEC on April 8, 2022 for further information. Loss Contingencies In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. If applicable, the Company accrues receivables for probable insurance or other third-party recoveries. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use o f contractors in certain foreign countries. As of July 31, 2022 and January 31, 2022 , the estimated liability relating to these matters was $2.5 million and $2.6 million, respectively. Warranties and Indemnifications The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the condensed consolidated financial statements. In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments. In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid. Legal Proceedings The Company is, and from time to time, may become involved in legal proceedings or be subject to claims arising in the ordinary course of its business. The Company is not presently a party to any legal proceedings that in the opinion of management, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, financial condition or operating results.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP.
Correction of an Immaterial Error in Prior Period	Correction of an Immaterial Error in Prior Period During the quarter ended October 31, 2021, the Company identified an immaterial error in which $50.0 million of short-term investments were incorrectly reflected within cash and cash equivalents as previously reported for the six months ended July 31, 2021. In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 250, Accounting Changes and Error Corrections
Fiscal Year	Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal 2023 and 2022 refer to the fiscal year ending January 31, 2023 and the fiscal year ended January 31, 2022, respectively.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes and valuation of intangibles assets . The Company bases these estimates on historical and anticipated results, tre nds, and various other assumptions, including the impact of the COVID-19 pandemic, that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. The novel coronavirus, or COVID-19, pandemic has created, and may continue to create, significant uncertainty in macroeconomic conditions. The global impact of COVID-19 continues to rapidly evolve, and the Company will continue to monitor the situation and the effects on its business and operations closely. The Company does not yet know the full extent of potential impacts on its business or operations or on the global economy as a whole, particularly if the COVID-19 pandemic continues and persists for an extended period of time.
Principles of Consolidation	Principles of ConsolidationThe condensed consolidated financial statements include 100% of the accounts of wholly owned subsidiaries and a variable interest entity for which our Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Short-Term Investments	Short-Term Investments - Marketable Securities The Company classifies its marketable securities with stated maturities of three months and greater as short-term investments due to its ability to use these securities to support the Company’s current operations. As of July 31, 2022, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. Unrealized gains and losses are recorded as a separate component of other comprehensive loss, net of tax. Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the condensed consolidated statements of operations. The Company periodically reviews its available-for-sale securities to determine if there has been an other-than-temporary decline in fair value. Factors considered in determining whether a loss is other-than-temporary include, but are not limited to: the length of time and extent a security’s fair value has been below its cost, the financial condition and near-term prospects of the investee, the credit quality of the security’s issuer, likelihood of recovery and the Company’s intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. No changes in fair value due to impairment have been recorded in earnings for available-for-sale securities during the periods presented.
Equity Method Investments	Equity Method Investment The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in an erstwhile subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in our condensed consolidated statements of operations. The carrying value of the Company’s equity method investments is reported in equity method investment in the condensed consolidated balance sheets. The Company assesses investments
Stock-Based Compensation	Stock-Based Compensation Our PSUs issued to the senior members of its management team are subject to a revenue performance condition and service conditions. The number of PSUs that will ultimately vest will depend on the revenue achieved by the Company in fiscal 2025 relative to the defined target. The fair value of PSUs is measured at the market price of the Company’s Class A common stock on the date of grant and compensation costs related to these awards are recognized on a graded-vesting method over the requisite service period.
Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted	Recently Adopted Accounting Standards In December 2019, the FASB issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC 740, Income Taxes in order to reduce cost and complexity of its application. The Company adopted ASU 2019-12 as of February 1, 2022 with no material impact. Recently Issued Accounting Standards Not Yet Adopted In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820) (“Topic 820”): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (“ASU 2022-03”). ASU 2022-03 clarifies the guidance in Topic 820 that a contractual restriction on the sale of an equity security should not be considered in measuring fair value, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. For public companies, the amendments to ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. The adoption of ASU 2022-03 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“Topic 842”). Topic 842 supersedes the lease requirements in ASC Topic 840, Leases . Under Topic 842, lessees are required to recognize assets and liabilities on the condensed consolidated balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. For public companies, Topic 842 is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company has elected to use the extended transition period that allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies under the JOBS Act. For as long as the Company remains an “emerging growth company,” the new guidance is effective for annual reporting periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The adoption of ASU 2016-02 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. Since the Company follows private company’s adoption timelines, this new guidance is effective for the Company for its fiscal year beginning February 1, 2023. The Company is currently evaluating the effect of the adoption of ASU 2016-13 on its condensed consolidated financial statements. The effect will largely depend on the composition and credit quality of the Company's portfolio of financial assets and the economic conditions at the time of adoption.
Fair Value of Financial Instruments	The Company determines fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instrumen ts such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models.

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Subscription—self-managed and SaaS $ 88,936 88 % $ 51,860 89 % $ 165,859 88 % $ 96,768 90 % Subscription—self-managed 66,896 66 41,412 71 126,615 67 77,527 72 SaaS 22,040 22 10,448 18 39,244 21 19,241 18 License—self-managed and other $ 12,105 12 % $ 6,267 11 % $ 22,589 12 % $ 11,289 10 % License—self-managed 10,009 10 4,776 8 18,786 10 8,443 8 Professional services and other 2,096 2 1,491 3 3,803 2 2,846 2 Total revenue $ 101,041 100 % $ 58,127 100 % $ 188,448 100 % $ 108,057 100 %
Revenue from External Customers by Geographic Areas	The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 United States $ 84,123 $ 48,833 $ 156,397 $ 90,520 Europe 14,750 8,353 27,738 15,466 Asia Pacific 2,168 941 4,313 2,071 Total revenue $ 101,041 $ 58,127 $ 188,448 $ 108,057

Cash, Cash Equivalents and Sh_2

Cash, Cash Equivalents and Short-Term Investments (Tables)	6 Months Ended
	Jul. 31, 2022
Cash and Cash Equivalents [Abstract]
Schedule of Short Term Investments	The following table summarizes the Company’s cash, cash equivalents and short-term investments by category (in thousands): As of July 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 281,339 $ — $ — $ 281,339 Money market funds 111,927 — — 111,927 U.S. Treasury securities 7,499 — — 7,499 U.S. Agency securities 9,996 — (4) 9,992 Total cash and cash equivalents $ 410,761 $ — $ (4) $ 410,757 Short-term investments: Commercial paper 46,197 — (190) 46,007 Corporate debt securities 48,251 17 (202) 48,066 Municipal bonds 1,974 — (11) 1,963 Foreign government bonds 2,185 — (7) 2,178 U.S. Agency securities 18,585 20 (35) 18,570 U.S. Treasury securities 404,760 10 (2,121) 402,649 Total short-term investments $ 521,952 $ 47 $ (2,566) $ 519,433
Schedule of Unrealized Losses Cash Equivalents and Short Term Investment	The following table summarizes unrealized losses on our cash equivalents and short-term investments by category that have been in a continuous unrealized loss position for less than 12 months as of the periods presented (in thousands): Carrying Value Gross Unrealized Losses July 31, 2022 U.S. Agency securities $ 21,107 $ (39) Commercial paper 46,007 (190) Corporate debt securities 38,112 (202) Municipal bonds 1,963 (11) Foreign government bonds 2,178 (7) U.S. Treasury securities 398,843 (2,121) Total cash equivalents and short-term investments $ 508,210 $ (2,570)
Schedule of Short Term Investments by Contractual Maturity	The following table classifies the Company’s short-term investments by contractual maturities (in thousands): July 31, 2022 January 31, 2022 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 375,663 $ 373,816 $ 50,031 $ 50,031 Due between 1 year to 3 years 146,289 145,617 — — Total $ 521,952 $ 519,433 $ 50,031 $ 50,031

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on Recurring Basis	Financial assets measured at fair value on a recurring basis are summarized below (in thousands): Level 1 Level 2 Level 3 Fair Value July 31, 2022 (1) Cash equivalents: Money market funds $ 111,927 $ — $ — $ 111,927 U.S. Agency securities — 7,499 — 7,499 U.S. Treasury securities — 9,992 — 9,992 Short-term investments: Commercial paper — 46,007 — 46,007 Corporate debt securities — 48,066 — 48,066 Municipal bonds — 1,963 — 1,963 Foreign government bonds — 2,178 — 2,178 U.S. Agency securities — 18,570 — 18,570 U.S. Treasury securities — 402,649 — 402,649 Total $ 111,927 $ 536,924 $ — $ 648,851 (1) Exclu des $281.3 million in cash held in the Company’s bank accounts as of July 31, 2022.

Supplemental Financial Statem_2

Supplemental Financial Statement Information (Tables)	6 Months Ended
	Jul. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2022 January 31, 2022 Prepaid software subscriptions $ 5,084 $ 3,950 Prepaid advertising costs 1,624 722 Security and other deposits 1,620 981 Prepaid insurance 1,221 4,309 Prepaid income taxes 3,678 3,168 Restricted cash (1) 2,500 — Interest receivable 1,294 49 Prepaid expenses for the Company’s events 715 266 Other prepaid expenses 733 1,834 Other current assets 2,338 265 Total prepaid expense and other current assets $ 20,807 $ 15,544 (1) Refer to “Note 7. Business Combination”.
Property, Plant and Equipment	Property and equipment, net of the following (in thousands): July 31, 2022 January 31, 2022 Computer and office equipment $ 6,480 $ 3,049 Leasehold improvements 768 765 Others 92 — 7,340 3,814 Less: Accumulated depreciation (1) (1,881) (543) Total property and equipment, net (1) $ 5,459 $ 3,271 (1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment.
Schedule of Other Assets, Noncurrent	Other assets consisted of the following (in thousands): July 31, 2022 January 31, 2022 Security and other deposits $ 2,298 $ 2,832 Restricted cash (1) — 2,500 Deferred software implementation costs 1,119 969 Other long-term assets 802 850 Total other long-term assets $ 4,219 $ 7,151 (1) Refer to “Note 7. Business Combination”.
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2022 January 31, 2022 Accrued expenses $ 12,881 $ 8,605 Income taxes payable 1,127 319 ESPP employee contributions 2,130 6,557 Indirect taxes payable 1,169 4,044 Acquisition related contingent cash consideration (1) 3,101 3,029 Acquisition related consideration withheld in escrow (1) 2,500 — Other current liabilities 1,566 2,017 Total accrued expenses and other current liabilities $ 24,474 $ 24,571 (1) Refer to “Note 7. Business Combination”.
Schedule of Accounts Payable and Accrued Liabilities	Accrued compensation and benefits consisted of the following (in thousands): July 31, 2022 January 31, 2022 Accrued commissions $ 6,745 $ 8,417 Payroll taxes payable 1,382 14,506 Other accrued team member related payables 7,376 9,897 Total accrued compensation and benefits $ 15,503 $ 32,820
Other Noncurrent Liabilities	Other long-term liabilities consisted of the following (in thousands): July 31, 2022 January 31, 2022 Early exercised options liability $ 3,775 $ 6,837 Acquisition related contingent cash consideration (1) 5,046 4,929 Acquisition related consideration withheld in escrow (1) — 2,500 Deferred tax liabilities 1,725 379 Contingent liability for labor matters 2,510 2,573 Other long-term liabilities 938 784 Total other long-term liabilities $ 13,994 $ 18,002 (1) Refer to “Note 7. Business Combination”.
Other Income (Expense), Net	Other income (expense), net consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Gain from deconsolidation of Meltano Inc. (1) $ — $ — $ 17,798 $ — Foreign exchange gains (losses), net 1,646 (8,821) 2,506 (9,872) Other expense, net (146) (1,170) (356) (1,171) Total other income (expense), net $ 1,500 $ (9,991) $ 19,948 $ (11,043) (1) Refer to “Note 11. Joint Venture and Equity Method Investment”.

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Jul. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	The transaction was accounted for as a business combination. The acquisition date fair value of the consideration transferred consisted of the following (in thousands): Cash consideration $ 2,970 Fair value of common stock issued on closing 959 Contingent common stock consideration (classified under additional paid-in capital) 1,754 Contingent cash consideration (classified under accrued expenses and other current liabilities as of July 31, 2022) 3,007 Contingent cash consideration (classified under other long-term liabilities as of July 31, 2022) 4,893 Total consideration $ 13,583

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	6 Months Ended
	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of July 31, 2022 and January 31, 2022 $ 8,145
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): July 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (1,359) $ 4,841 2.3 Developed technology from asset acquisitions (1) 1,284 (1,044) 240 0.7 Total $ 7,484 $ (2,403) $ 5,081 January 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (334) $ 5,866 2.8 Developed technology from asset acquisitions (1) 1,402 (983) 419 1.3 Total $ 7,602 $ (1,317) $ 6,285 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination	As of July 31, 2022 , future amortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2023 $ 1,188 2024 2,166 2025 1,727 Total future amortization $ 5,081

Equity (Tables)

Equity (Tables)	6 Months Ended
	Jul. 31, 2022
Equity [Abstract]
Schedule of Stock Reserved For Future Issuance	The Company had shares of common stock reserved for future issuance as follows (in thousands): July 31, 2022 January 31, 2022 Class A and Class B common stock Options issued and outstanding 14,888 17,146 Shares available for issuance under Equity Incentive Plans 21,870 18,248 RSUs and PSUs issued and outstanding 7,972 3,280 Shares reserved for issuance to charitable organizations 1,636 1,636 2021 ESPP 4,451 3,271 Total 50,817 43,581
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): July 31, 2022 January 31, 2022 Available at beginning of period 18,248 4,796 Awards authorized 7,673 22,532 Options granted — (7,936) RSUs and PSUs granted (5,103) (3,290) RSUs cancelled and forfeited 161 10 Options cancelled and forfeited 849 2,044 Options repurchased 42 92 Available at end of period 21,870 18,248
Share-based Payment Arrangement, Option, Activity	The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2022 17,146 $ 11.83 8.24 $ 894.8 Options granted — — Options exercised (1,409) 8.29 Options cancelled (14) 10.02 Options forfeited (835) 13.60 Balances at July 31, 2022 14,888 $ 12.06 7.73 $ 675.0 Options vested at July 31, 2022 6,663 $ 8.24 7.02 $ 327.6 Options vested and expected to vest at July 31, 2022 14,888 $ 12.06 7.73 $ 675.0
Schedule of Restricted Stock Units Activity	The following table summarizes the Company’s restricted stock units activity (in thousands): Number of Shares (1) Weighted- Balances at January 31, 2022 272 $ 82.11 Granted 4,738 52.28 Vested (242) 59.45 Canceled/forfeited (161) 58.47 Balances at July 31, 2022 4,607 $ 53.38
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model: Six Months Ended July 31, 2022 Risk-free interest rate 1.62% - 2.63% Volatility 44.95% - 52.76% Expected term (in years) 0.5 - 2.0 Dividend yield —%
Share-based Payment Arrangement, Expensed and Capitalized, Amount	The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Cost of revenue $ 1,585 $ 239 $ 2,375 $ 391 Research and development 11,339 1,541 16,375 2,506 Sales and marketing 14,851 1,687 21,902 3,126 General and administrative 9,972 1,765 14,566 2,640 Total stock-based compensation expense $ 37,747 $ 5,232 $ 55,218 $ 8,663

Joint Venture and Equity Meth_2

Joint Venture and Equity Method Investment (Tables)	6 Months Ended
	Jul. 31, 2022
Noncontrolling Interest [Abstract]
Schedule of Variable Interest Entities	Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Revenue $ 1,020 $ 32 $ 2,113 $ 32 Cost of revenue 413 274 712 361 Gross profit (loss) 607 (242) 1,401 (329) Operating expenses: Sales and marketing 1,865 705 3,252 850 Research and development 1,909 333 2,837 661 General and administrative 3,539 945 4,293 1,579 Total operating expenses 7,313 1,983 10,382 3,090 Loss from operations (6,706) (2,225) (8,981) (3,419) Interest income 142 — 210 — Other income, net 339 49 1,012 1 Net loss before income taxes (6,225) (2,176) (7,759) (3,418) Net loss $ (6,225) $ (2,176) $ (7,759) $ (3,418) Net loss attributable to noncontrolling interest $ (2,473) $ (577) $ (2,987) $ (922) July 31, 2022 January 31, 2022 Cash and cash equivalents $ 58,323 $ 14,198 Property and equipment, net 845 769 Other assets 1,777 2,765 Total assets $ 60,945 $ 17,732 Total liabilities $ 3,589 $ 3,663

Net Loss per Share (Tables)

Net Loss per Share (Tables)	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Numerator: Net loss attributable to GitLab $ (59,024) $ (40,189) $ (85,123) $ (68,126) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 147,797 53,424 147,248 52,941 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.40) $ (0.75) $ (0.58) $ (1.29)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): July 31, 2022 January 31, 2022 Shares subject to outstanding common stock options 14,888 17,146 Unvested RSUs in connection with business combination 15 16 Unvested early exercised stock options 388 714 Unvested RSUs and PSUs 7,972 3,264 Shares subject to the 2021 ESPP 65 256 Total 23,328 21,396

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash and cash equivalents	$ 413,257	$ 226,254	$ 887,172		$ 282,850
Purchases of short-term investments	$ 520,664	$ 50,000
Revision of prior period adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash and cash equivalents				$ 50,000

Revenues - Disaggregation of Re

Revenues - Disaggregation of Revenue by Product and Service (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 101,041	$ 58,127	$ 188,448	$ 108,057
Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100%	100%	100%	100%
Subscription—self-managed and SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 88,936	$ 51,860	$ 165,859	$ 96,768
Subscription—self-managed and SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	88%	89%	88%	90%
Subscription—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 66,896	$ 41,412	$ 126,615	$ 77,527
Subscription—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	66%	71%	67%	72%
SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 22,040	$ 10,448	$ 39,244	$ 19,241
SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	22%	18%	21%	18%
License—self-managed and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 12,105	$ 6,267	$ 22,589	$ 11,289
License—self-managed and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	12%	11%	12%	10%
License—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 10,009	$ 4,776	$ 18,786	$ 8,443
License—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	10%	8%	10%	8%
Professional services and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 2,096	$ 1,491	$ 3,803	$ 2,846
Professional services and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	2%	3%	2%	2%

Revenues - Disaggregation of _2

Revenues - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 101,041	$ 58,127	$ 188,448	$ 108,057
United States
Disaggregation of Revenue [Line Items]
Total revenue	84,123	48,833	156,397	90,520
Europe
Disaggregation of Revenue [Line Items]
Total revenue	14,750	8,353	27,738	15,466
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 2,168	$ 941	$ 4,313	$ 2,071

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Disaggregation of Revenue [Line Items]
Deferred revenue recognized	$ 67	$ 39.8	$ 105.8	$ 61.3
Remaining performance obligation	$ 361.9		$ 361.9		$ 312.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-05-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	69%		69%
Period of expected satisfaction (in months)	12 months		12 months
Accounts Receivable | Credit Concentration Risk | Two Distribution Channels
Disaggregation of Revenue [Line Items]
Concentration risk, percentage			35%
Accounts Receivable | Credit Concentration Risk | Two Distribution Channels - Entity One
Disaggregation of Revenue [Line Items]
Concentration risk, percentage			19%
Accounts Receivable | Credit Concentration Risk | Two Distribution Channels - Entity Two
Disaggregation of Revenue [Line Items]
Concentration risk, percentage			16%
Accounts Receivable | Credit Concentration Risk | One Distribution Channel
Disaggregation of Revenue [Line Items]
Concentration risk, percentage					14%
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	83%	84%	83%	84%

Cash, Cash Equivalents and Sh_3

Cash, Cash Equivalents and Short-Term Investments - Schedule of Cash and Short Term Investments (Details) $ in Thousands	Jul. 31, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 521,952
Gross Unrealized Gains	47
Gross Unrealized Losses	(2,566)
Fair Value	519,433
Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	410,761
Gross Unrealized Gains	0
Gross Unrealized Losses	(4)
Fair Value	410,757
Cash | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	281,339
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	281,339
Money market funds | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	111,927
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	111,927
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	46,197
Gross Unrealized Gains	0
Gross Unrealized Losses	(190)
Fair Value	46,007
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	48,251
Gross Unrealized Gains	17
Gross Unrealized Losses	(202)
Fair Value	48,066
Municipal bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,974
Gross Unrealized Gains	0
Gross Unrealized Losses	(11)
Fair Value	1,963
Foreign government bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,185
Gross Unrealized Gains	0
Gross Unrealized Losses	(7)
Fair Value	2,178
U.S. Agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	18,585
Gross Unrealized Gains	20
Gross Unrealized Losses	(35)
Fair Value	18,570
U.S. Agency securities | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	9,996
Gross Unrealized Gains	0
Gross Unrealized Losses	(4)
Fair Value	9,992
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	404,760
Gross Unrealized Gains	10
Gross Unrealized Losses	(2,121)
Fair Value	402,649
U.S. Treasury securities | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	7,499
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	$ 7,499

Cash, Cash Equivalents and Sh_4

Cash, Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Cash and Cash Equivalents [Line Items]
Cash				$ 884,700
Interest and investment income	$ 3,100	$ 3,100
Short-term investments	$ 3,600	3,600
Net amortization of premiums or discounts on short-term investments		$ 1,293	$ 0
Certificates of Deposit
Cash and Cash Equivalents [Line Items]
Short-term investments				$ 50,000

Cash, Cash Equivalents and Sh_5

Cash, Cash Equivalents and Short-Term Investments - Schedule of Unrealized Losses Cash Equivalents and Short Term Investment (Details) $ in Thousands	Jul. 31, 2022 USD ($)
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	$ 508,210
Gross Unrealized Losses	(2,570)
Municipal bonds
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	1,963
Gross Unrealized Losses	(11)
Foreign government bonds
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	2,178
Gross Unrealized Losses	(7)
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	46,007
Gross Unrealized Losses	(190)
U.S. Agency securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	21,107
Gross Unrealized Losses	(39)
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	38,112
Gross Unrealized Losses	(202)
U.S. Treasury securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	398,843
Gross Unrealized Losses	$ (2,121)

Cash, Cash Equivalents and Sh_6

Cash, Cash Equivalents and Short-Term Investments - Schedule of Short Term Investments by Contractual Maturity (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Amortized cost
Due within 1 year	$ 375,663	$ 50,031
Due between 1 year to 3 years	146,289	0
Total	521,952	50,031
Fair Value
Due within 1 year	373,816	50,031
Due between 1 year to 3 years	145,617	0
Total	$ 519,433	$ 50,031

Fair Value Measurements (Detail

Fair Value Measurements (Details) $ in Thousands	Jul. 31, 2022 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	$ 519,433
Cash held in bank accounts	521,952
Contingent cash consideration	7,900
Cash
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash held in bank accounts	281,300
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	648,851
Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	111,927
Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	536,924
Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	46,007
Cash held in bank accounts	46,197
Commercial paper | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	46,007
Commercial paper | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Commercial paper | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	46,007
Commercial paper | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	48,066
Cash held in bank accounts	48,251
Corporate debt securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	48,066
Corporate debt securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Corporate debt securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	48,066
Corporate debt securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,963
Cash held in bank accounts	1,974
Municipal bonds | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,963
Municipal bonds | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Municipal bonds | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,963
Municipal bonds | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Foreign government bonds | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	2,178
Foreign government bonds | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Foreign government bonds | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	2,178
Foreign government bonds | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Agency securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	18,570
U.S. Agency securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Agency securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	18,570
U.S. Agency securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	402,649
Cash held in bank accounts	404,760
U.S. Treasury securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	402,649
U.S. Treasury securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Treasury securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	402,649
U.S. Treasury securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Money market funds | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	111,927
Money market funds | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	111,927
Money market funds | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Money market funds | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Agency securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	7,499
U.S. Agency securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Agency securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	7,499
U.S. Agency securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Treasury securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	9,992
U.S. Treasury securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Treasury securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	9,992
U.S. Treasury securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 0

Supplemental Financial Statem_3

Supplemental Financial Statement Information - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022		Jan. 31, 2022	Jul. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid software subscriptions	$ 5,084		$ 3,950
Prepaid advertising costs	1,624		722
Security and other deposits	1,620		981
Prepaid insurance	1,221		4,309
Prepaid income taxes	3,678		3,168
Restricted cash	2,500		0	$ 0
Interest receivable	1,294		49
Prepaid expenses for the Company’s events	715		266
Other prepaid expenses	733		1,834
Other current assets	2,338		265
Total prepaid expense and other current assets	$ 20,807	[1]	$ 15,544
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_4

Supplemental Financial Statement Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jul. 31, 2022		Jul. 31, 2021	Jul. 31, 2022		Jul. 31, 2021	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 7,340			$ 7,340			$ 3,814
Less: Accumulated depreciation	(1,881)			(1,881)			(543)
Property and equipment, net	5,459	[1]		5,459	[1]		3,271
Depreciation	700		$ 0	1,300		$ 0
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,480			6,480			3,049
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	768			768			765
Others
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 92			$ 92			$ 0
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_5

Supplemental Financial Statement Information - Schedule of Other Long-Term Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022		Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Security and other deposits	$ 2,298		$ 2,832
Restricted cash (1)	0		2,500
Deferred software implementation costs	1,119		969
Other long-term assets	802		850
Other long-term assets	$ 4,219	[1]	$ 7,151
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_6

Supplemental Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022		Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 12,881		$ 8,605
Income taxes payable	1,127		319
ESPP employee contributions	2,130		6,557
Indirect taxes payable	1,169		4,044
Acquisition related contingent cash consideration (1)	3,101		3,029
Acquisition related consideration withheld in escrow (1)	2,500		0
Other current liabilities	1,566		2,017
Accrued expenses and other current liabilities	$ 24,474	[1]	$ 24,571
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_7

Supplemental Financial Statement Information - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued commissions	$ 6,745	$ 8,417
Payroll taxes payable	1,382	14,506
Other accrued team member related payables	7,376	9,897
Total accrued compensation and benefits	$ 15,503	$ 32,820

Supplemental Financial Statem_8

Supplemental Financial Statement Information - Other Long-Term Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022		Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Early exercised options liability	$ 3,775		$ 6,837
Acquisition related contingent cash consideration (1)	5,046		4,929
Acquisition related consideration withheld in escrow (1)	0		2,500
Deferred tax liabilities	1,725		379
Contingent liability for labor matters	2,510		2,573
Other long-term liabilities	938		784
Total other long-term liabilities	$ 13,994	[1]	$ 18,002
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_9

Supplemental Financial Statement Information - Other Income (Expense), Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Other Income and Expenses [Abstract]
Gain from deconsolidation of Meltano Inc.	$ 0	$ 0	$ 17,798	$ 0
Foreign exchange gains (losses), net	1,646	(8,821)	2,506	(9,872)
Other expense, net	(146)	(1,170)	(356)	(1,171)
Total other income (expense), net	$ 1,500	$ (9,991)	$ 19,948	$ (11,043)

Business Combination - Schedule

Business Combination - Schedule of Total Consideration Transferred (Details) - USD ($) $ in Thousands	Dec. 03, 2021	Jul. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Contingent cash consideration (classified under accrued expenses and other current liabilities as of July 31, 2022)		$ 3,101	$ 3,029
Opstrace Inc.
Business Acquisition [Line Items]
Cash consideration	$ 2,970
Fair value of common stock issued on closing	959
Contingent common stock consideration (classified under additional paid-in capital)	1,754
Contingent cash consideration (classified under accrued expenses and other current liabilities as of July 31, 2022)	3,007
Contingent cash consideration (classified under other long-term liabilities as of July 31, 2022)	4,893
Consideration transferred	$ 13,583

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) $ in Millions		3 Months Ended	6 Months Ended
	Dec. 03, 2021	Jul. 31, 2022	Jul. 31, 2022
Business Acquisition [Line Items]
Contingent cash consideration		$ 7.9	$ 7.9
Accretion expense		$ 0.1	$ 0.2
Opstrace Inc.
Business Acquisition [Line Items]
Cash consideration held back	$ 2.5
Post-closing indemnification term	18 months

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Rollforward of Goodwill (Details) - USD ($) $ in Thousands	Jul. 31, 2022		Jan. 31, 2022
Goodwill [Roll Forward]
Goodwill	$ 8,145	[1]	$ 8,145
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment		$ 0		$ 0
Amortization of intangible assets	$ 600		$ 100	$ 1,176	$ 169

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Apr. 30, 2022	Jul. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 7,484	$ 7,602
Accumulated Amortization		(2,403)	(1,317)
Net Book Value		5,081	6,285
Developed technology from business combination
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		6,200	6,200
Accumulated Amortization		(1,359)	(334)
Net Book Value		$ 4,841	5,866
Weighted average remaining amortization period (years)	2 years 9 months 18 days	2 years 3 months 18 days
Developed technology from asset acquisition
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 1,284	1,402
Accumulated Amortization		(1,044)	(983)
Net Book Value		$ 240	$ 419
Weighted average remaining amortization period (years)	1 year 3 months 18 days	8 months 12 days

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 1,188
2024	2,166
2025	1,727
Total future amortization	$ 5,081	$ 6,285

Team Member Benefit Plans (Deta

Team Member Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Retirement Benefits [Abstract]
Defined contribution plan, contribution amount	$ 0.8	$ 0.5	$ 2	$ 1.5

Equity - Narrative (Details)

Equity - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended				3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2022 shares	May 31, 2022 USD ($)	Sep. 30, 2021 date shares	May 31, 2021 USD ($) shares	Jul. 31, 2022 USD ($) vote $ / shares shares	Jul. 31, 2021 USD ($)	Apr. 30, 2021	Jul. 31, 2022 USD ($) vote $ / shares shares	Jul. 31, 2021 USD ($) $ / shares	Oct. 31, 2016	Jan. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2021	Oct. 18, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares) | shares					50,000,000			50,000,000			50,000,000		50,000,000
Preferred stock, par value (in USD per share) | $ / shares					$ 0.0000025			$ 0.0000025			$ 0.0000025		$ 0.0000025
Shares subject to repurchase obligation (in shares) | shares					388,331			388,331			713,967
Deferred compensation liability, noncurrent					$ 3,800			$ 3,800			$ 6,800
Options granted (in USD per share) | $ / shares									$ 8.35
Weighted average grant date fair value (in dollars per share) | $ / shares									$ 7.90
Intrinsic value of options exercised					25,800	$ 8,500
Aggregate intrinsic value, options vested								59,800	$ 25,800
Compensation expense not yet recognized					62,400			62,400			$ 80,300
Stock-based compensation					37,747	5,232		55,218	8,663
Issuance of common stock under employee stock purchase plan					9,554			9,554
Grant date fair value of RSUs granted				$ 8,800
Number of purchase dates | date			4
Tax benefit for stock-based compensation expense					$ 2,200	$ 0		$ 3,100	$ 0
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) | shares					1,500,000,000			1,500,000,000			1,500,000,000		1,500,000,000
Common stock, par value (in USD per share) | $ / shares					$ 0.0000025			$ 0.0000025			$ 0.0000025		$ 0.0000025
Voting rights, vote per share | vote					1			1
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) | shares					250,000,000			250,000,000			250,000,000		250,000,000
Common stock, par value (in USD per share) | $ / shares					$ 0.0000025			$ 0.0000025			$ 0.0000025		$ 0.0000025
Voting rights, vote per share | vote					10			10
RSUs granted in period (in shares) | shares				3,000,000
2021 Equity Incentive Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares) | shares			13,032,289
Shares subject to the 2021 ESPP | 2021 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)								1 year 9 months 18 days
Stock-based compensation					$ 9,700			$ 14,100
Compensation expense not yet recognized					31,700			31,700
Issuance of common stock under employee stock purchase plan		$ 300
Discount rate (as a percent)			15%
Look-back period (in months)			27 months
Tax benefit for stock-based compensation expense					700			700
Plan modification, cost not yet recognized					9,200			$ 9,200
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)								2 years 4 months 24 days				2 years 8 months 12 days
Stock options | 2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)										10 years
Stock options | 2015 Equity Incentive Plan | Period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage										25%
Award vesting period (in years)										1 year
Stock options | 2015 Equity Incentive Plan | Period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)										36 months
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense not yet recognized					235,700			$ 235,700			$ 21,500
Period for recognition (in years)							3 years 10 months 24 days	3 years 6 months
RSUs granted in period (in shares) | shares								5,103,000			3,290,000
RSUs | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation					400			$ 800
Compensation expense not yet recognized					6,800			$ 6,800
RSUs | Chief Executive Officer | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)								2 years
RSUs | Chief Executive Officer | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)								7 years
RSUs | 2021 Equity Incentive Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)								2 years
RSUs | 2021 Equity Incentive Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)								4 years
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	100%
Period for recognition (in years)								3 years 4 months 24 days
RSUs granted in period (in shares) | shares	400,000
Stock-based compensation								$ 700
Compensation expense not yet recognized					$ 18,500			$ 18,500
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	0%
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	200%

Equity - Schedule of Stock Rese

Equity - Schedule of Stock Reserved For Future Issuance (Details) - shares	Jul. 31, 2022	Jan. 31, 2022	Jan. 31, 2021
Class of Stock [Line Items]
Options issued and outstanding (in shares)	14,888,000	17,146,000
Shares available for issuance under Equity Incentive Plans (in shares)	21,870,000	18,248,000	4,796,000
Class A and Class B common stock
Class of Stock [Line Items]
Options issued and outstanding (in shares)		17,146,000
Shares reserved for issuance to charitable organizations (in shares)	1,636,000	1,636,000
Common stock reserved for future issuance (in shares)	50,817,000	43,581,000
Unvested RSUs and PSUs | Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	7,972,000	3,280,000
Shares subject to the 2021 ESPP | Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	4,451,000	3,271,000

Equity - Awards Available for G

Equity - Awards Available for Grant (Details) - shares	3 Months Ended	6 Months Ended	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2022	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
Balance, beginning of period (in shares)		18,248,000	4,796,000
Awards authorized (in shares)		7,673,000	22,532,000
Options granted (in shares)	0	0	(7,936,000)
Options cancelled and forfeited (in shares)		849,000	2,044,000
Options repurchased (in shares)		42,000	92,000
Balance, end of period (in shares)	21,870,000	21,870,000	18,248,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
RSUs granted (in shares)		(5,103,000)	(3,290,000)
RSUs cancelled and forfeited (in shares)		161,000	10,000

Equity - Summary of Stock Optio

Equity - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended	12 Months Ended
	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2022	Jan. 31, 2022
Number of Stock Options Outstanding (in thousands)
Balance, beginning of period (in shares)		17,146,000	17,146,000
Options granted (in shares)	0		0	7,936,000
Options exercised (in shares)			(1,409,000)
Options cancelled (in shares)			(14,000)
Options forfeited (in shares)			(835,000)
Balance, end of period (in shares)	14,888,000		14,888,000	17,146,000
Options vested (in shares)	6,663,000		6,663,000
Options expected to vest (in shares)	14,888,000		14,888,000
Weighted Average Exercise Price
Balance, beginning of period (in USD per share)		$ 11.83	$ 11.83
Options granted (in USD per share)			0
Options exercised (in USD per share)			8.29
Options cancelled (in USD per share)			10.02
Options forfeited (in USD per share)			13.60
Balance, end of period (in USD per share)	$ 12.06		12.06	$ 11.83
Options vested (in USD per share)			8.24
Options expected to vest (in USD per share)			$ 12.06
Weighted Average Remaining Years
Beginning balance (in years)		8 years 2 months 26 days	7 years 8 months 23 days
Options granted (in years)
Options exercised (in years)
Options vested (in years)			7 years 7 days
Options expected to vest (in years)			7 years 8 months 23 days
Aggregate Intrinsic value (in millions)
Beginning balance		$ 894.8	$ 894.8
Ending balance	$ 675		675	$ 894.8
Options vested	327.6		327.6
Options expected to vest	$ 675		$ 675

Equity - Schedule of Restricted

Equity - Schedule of Restricted Stock Units Activity (Details) - RSUs	6 Months Ended
	Jul. 31, 2022 $ / shares shares
Number of Shares
Balance, beginning of period (in shares)	272,000
Granted (in shares)	4,738,000
Exercised (in shares)	(242,000)
Canceled/forfeited (in shares)	(161,000)
Balance, ending of period (in shares)	4,607,000
Weighted- Average grant date fair value
Balance, beginning of period (in USD per share) | $ / shares	$ 82.11
Granted (in USD per share) | $ / shares	52.28
Exercised (in USD per share) | $ / shares	59.45
Canceled/forfeited (in USD per share) | $ / shares	58.47
Balance, ending of period (in USD per share) | $ / shares	$ 53.38
Chief Executive Officer
Number of Shares
Granted (in shares)	3,000,000

Equity - Schedule of Weighted A

Equity - Schedule of Weighted Average Fair Value Assumptions (Details) - Shares subject to the 2021 ESPP	6 Months Ended
	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield (as a percent)	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	1.62%
Volatility (as a percent)	44.95%
Expected term (in years)	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	2.63%
Volatility (as a percent)	52.76%
Expected term (in years)	2 years

Equity - Stock-Based Compensati

Equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 37,747	$ 5,232	$ 55,218	$ 8,663
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	1,585	239	2,375	391
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	11,339	1,541	16,375	2,506
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	14,851	1,687	21,902	3,126
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 9,972	$ 1,765	$ 14,566	$ 2,640

Joint Venture and Equity Meth_3

Joint Venture and Equity Method Investment - Narrative (Details) $ in Thousands, shares in Millions

1 Months Ended

3 Months Ended

6 Months Ended

Apr. 04, 2022 USD ($)

Mar. 29, 2022 USD ($)

Jul. 31, 2018 USD ($)

Apr. 30, 2021 USD ($)

Feb. 28, 2021 USD ($) day

Jul. 31, 2022 USD ($)

Jul. 31, 2021 USD ($)

Jul. 31, 2022 USD ($) shares

Jul. 31, 2021 USD ($)

Jan. 31, 2022 USD ($)

Noncontrolling Interest [Line Items]

Stock-based compensation expense

$ 37,747

$ 5,232

$ 55,218

$ 8,663

Contributions received from noncontrolling interests, net of issuance costs

57,673

26,450

Decrease in net assets upon consolidation

$ 9,400

Decrease from deconsolidation

11,342

Carrying value of investment

14,581

[1]

14,581

[1]

$ 0

Loss from equity method investment, net of tax

(816)

$ 0

(1,019)

$ 0

Shares subject to the 2021 ESPP | 2021 Employee Stock Purchase Plan

Noncontrolling Interest [Line Items]

Compensation expense not yet recognized

31,700

$ 31,700

Period for recognition (in years)

1 year 9 months 18 days

Meltano Inc.

Noncontrolling Interest [Line Items]

Equity method investment, cost

17,800

Stake in equity method investment (as a percent)

98%

Noncontrolling Interests

Noncontrolling Interest [Line Items]

Stock-based compensation expense

2,755

$ 2,972

Decrease from deconsolidation

11,300

11,342

Accumulated Deficit

Noncontrolling Interest [Line Items]

Decrease from deconsolidation

15,900

JiHu

Noncontrolling Interest [Line Items]

Consideration received on transaction, net of discounts

$ 27,700

Net of issuance costs

22,800

22,800

Stock-based compensation expense

2,800

3,000

Compensation expense not yet recognized

$ 20,600

$ 20,600

Period for recognition (in years)

3 years 8 months 12 days

Meltano Inc.

Noncontrolling Interest [Line Items]

Consideration received on transaction, net of discounts

$ 7,200

Contributions received from noncontrolling interests, net of issuance costs

$ 4,200

Meltano Inc. | Employee stock options

Noncontrolling Interest [Line Items]

Potentially dilutive equity instruments (in shares) | shares

2.6

Meltano Inc. | Preferred Stock

Noncontrolling Interest [Line Items]

Stake in equity method investment (as a percent)

50%

Potentially dilutive equity instruments (in shares) | shares

3.1

JiHu

Noncontrolling Interest [Line Items]

Ownership percentage by noncontrolling owners

72%

Ownership percentage

56%

Meltano Inc.

Noncontrolling Interest [Line Items]

Ownership percentage by noncontrolling owners

12%

Investment in subsidiary

$ 400

Variable Interest Entity, Primary Beneficiary | JiHu

Noncontrolling Interest [Line Items]

Loans payable

$ 2,900

Loan payable, period (in days) | day

10

[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Joint Venture and Equity Meth_4

Joint Venture and Equity Method Investment - Schedule of Inter-Company Eliminations (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jul. 31, 2022		Jul. 31, 2021	Jul. 31, 2022		Jul. 31, 2021	Jan. 31, 2022
Noncontrolling Interest [Line Items]
Revenue	$ 101,041		$ 58,127	$ 188,448		$ 108,057
Cost of revenue	13,030		7,192	22,878		13,617
Gross profit	88,011		50,935	165,570		94,440
Sales and marketing	80,689		44,165	147,399		83,019
Research and development	39,520		22,603	71,350		43,943
General and administrative	33,104		13,998	54,996		23,337
Total operating expenses	153,313		80,766	273,745		150,299
Loss from operations	(65,302)		(29,831)	(108,175)		(55,859)
Interest income	3,064		45	3,590		99
Total other income (expense), net	1,500		(9,991)	19,948		(11,043)
Net loss	(61,497)		(40,766)	(88,110)		(69,048)
Net loss attributable to noncontrolling interest	(2,473)		(577)	(2,987)		(922)
Cash and cash equivalents	410,757	[1]	226,254	410,757	[1]	226,254	$ 884,672
Property and equipment, net	5,459	[1]		5,459	[1]		3,271
Total assets	1,115,419	[1]		1,115,419	[1]		1,091,438
Total liabilities	285,099	[1]		285,099	[1]		292,169
Variable Interest Entity, Primary Beneficiary
Noncontrolling Interest [Line Items]
Revenue	1,020		32	2,113		32
Cost of revenue	413		274	712		361
Gross profit	607		(242)	1,401		(329)
Sales and marketing	1,865		705	3,252		850
Research and development	1,909		333	2,837		661
General and administrative	3,539		945	4,293		1,579
Total operating expenses	7,313		1,983	10,382		3,090
Loss from operations	(6,706)		(2,225)	(8,981)		(3,419)
Interest income	142		0	210		0
Total other income (expense), net	339		49	1,012		1
Net loss before income taxes	(6,225)		(2,176)	(7,759)		(3,418)
Net loss	(6,225)		(2,176)	(7,759)		(3,418)
Net loss attributable to noncontrolling interest	(2,473)		$ (577)	(2,987)		$ (922)
Cash and cash equivalents	58,323			58,323			14,198
Property and equipment, net	845			845			769
Other assets	1,777			1,777			2,765
Total assets	60,945			60,945			17,732
Total liabilities	$ 3,589			$ 3,589			$ 3,663
[1](1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ (57)	$ 989	$ 2,454	$ 2,245
Loss before income taxes and loss from equity method investment	(60,738)	$ (39,777)	(84,637)	$ (66,803)
Unrecognized tax benefits	5,500		5,500
Unrecognized tax benefits that would effect tax rate	$ 800		800
Interest and penalties recognized			$ 100		$ 100

Net Loss per Share - Schedule o

Net Loss per Share - Schedule of Earning Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Earnings Per Share [Abstract]
Net loss attributable to GitLab, Basic	$ (59,024)	$ (40,189)	$ (85,123)	$ (68,126)
Net loss attributable to GitLab, Diluted	$ (59,024)	$ (40,189)	$ (85,123)	$ (68,126)
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic	147,797,000	53,424,000	147,248,000	52,941,000
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, diluted	147,797,000	53,424,000	147,248,000	52,941,000
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)	$ (0.40)	$ (0.75)	$ (0.58)	$ (1.29)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)	$ (0.40)	$ (0.75)	$ (0.58)	$ (1.29)

Net Loss per Share - Schedule_2

Net Loss per Share - Schedule of Potentially Dilutive Securities (Details) - shares shares in Thousands	3 Months Ended	6 Months Ended
	Apr. 30, 2022	Jul. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	21,396	23,328
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	17,146	14,888
Unvested RSUs in connection with business combination
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	16	15
Unvested early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	714	388
Unvested RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	3,264	7,972
Shares subject to the 2021 ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	256	65

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	6 Months Ended
	Jul. 31, 2022	Jan. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation period	3 years
Purchase obligation	$ 7.4
Purchase subscription	2.3
Estimate of possible loss	$ 2.5	$ 2.6